Literature DB >> 17197314

Graft incorporation after acetabular and femoral impaction grafting with washed irradiated allograft and autologous marrow.

Dan E Deakin1, Gordon C Bannister.   

Abstract

Rates of around 40% incorporation have been described when chips of irradiated cancellous allograft with retained fat were impacted with the Exeter technique. We report the results of acetabular and femoral impaction bone grafting during revision hip arthroplasty using washed irradiated allograft with autologous marrow. Eighty-five consecutive patients underwent acetabular and or femoral revision arthroplasty. Evidence of graft cortication and trabeculation was recorded on successive postoperative radiographs, over a mean period of 44 months. Ninety-six percent (49/51) and 90% (53/59) of patients showed incorporation in acetabular and femoral grafts, respectively. This was usually apparent by 6 months postoperatively. We conclude that the addition of autologous marrow to irradiated bone allograft during impaction grafting is a cheap and highly effective way of achieving graft incorporation.

Entities:  

Mesh:

Year:  2007        PMID: 17197314     DOI: 10.1016/j.arth.2006.02.162

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  13 in total

1.  The survival and fate of acetabular reconstruction with impaction grafting for large defects.

Authors:  Eduardo Garcia-Cimbrelo; Ana Cruz-Pardos; Eduardo Garcia-Rey; José Ortega-Chamarro
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

2.  Femoral impaction grafting.

Authors:  John A Scanelli; Thomas E Brown
Journal:  World J Orthop       Date:  2013-01-18

3.  Supercharging irradiated allografts with mesenchymal stem cells improves acetabular bone grafting in revision arthroplasty.

Authors:  Philippe Hernigou; Jacques Pariat; Steffen Queinnec; Yasuhiro Homma; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-02-09       Impact factor: 3.075

4.  Allografts supercharged with bone-marrow-derived mesenchymal stem cells possess equivalent osteogenic capacity to that of autograft: a study with long-term follow-ups of human biopsies.

Authors:  Philippe Hernigou; Arnaud Dubory; François Roubineau; Yasuhiro Homma; Charles Henri Flouzat-Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2016-08-24       Impact factor: 3.075

5.  Supercharging allografts with mesenchymal stem cells in the operating room during hip revision.

Authors:  Yasuhiro Homma; Kazuo Kaneko; Philippe Hernigou
Journal:  Int Orthop       Date:  2013-12-10       Impact factor: 3.075

6.  Favorable survival of acetabular reconstruction with bone impaction grafting in dysplastic hips.

Authors:  Matthijs P Somford; Stefan B T Bolder; Jean W M Gardeniers; Tom J J H Slooff; B Willem Schreurs
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

7.  Impaction grafting of the acetabulum with ceramic bone graft substitute: high survivorship in 43 patients with a mean follow-up period of 4 years.

Authors:  Michael R Whitehouse; Peter J Dacombe; Jason C J Webb; Ashley W Blom
Journal:  Acta Orthop       Date:  2013-08       Impact factor: 3.717

8.  Impaction bone grafting of the acetabulum at hip revision using a mix of bone chips and a biphasic porous ceramic bone graft substitute.

Authors:  Ashley W Blom; Vikki Wylde; Christine Livesey; Michael R Whitehouse; Steve Eastaugh-Waring; Gordon C Bannister; Ian D Learmonth
Journal:  Acta Orthop       Date:  2009-04       Impact factor: 3.717

9.  The quality assessment of the University hospital bone bank in Central Serbia: the second audit after fourteen years.

Authors:  Stepanovic L Zeljko; Ristic M Branko
Journal:  Cell Tissue Bank       Date:  2021-07-02       Impact factor: 1.522

10.  Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: high survivorship in 43 patients with a median follow-up of 7 years: a follow-up report.

Authors:  Michael R Whitehouse; Peter J Dacombe; Jason C J Webb; Ashley W Blom
Journal:  Acta Orthop       Date:  2013-04-17       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.